Biomarkers of Development of Immunity and Allergic Diseases in Farming and Non-farming Lifestyle Infants: Design, Methods and 1 Year Outcomes in the "Zooming in to Old Order Mennonites" Birth Cohort Study

• Published in: Frontiers in pediatrics Vol. 10; p. 916184
• Main Authors: Järvinen, Kirsi M, Davis, Erin C, Bevec, Erin, Jackson, Courtney M, Pizzarello, Catherine, Catlin, Elizabeth, Klein, Miranda, Sunkara, Akhila, Diaz, Nichole, Miller, James, Martina, Camille A, Thakar, Juilee, Seppo, Antti E, Looney, R John
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 06.07.2022
• Subjects: atopic dermatitis; farming lifestyle; food allergy; human milk; infant immunity; microbiome; Pediatrics; birth cohort; infant immunity; farming lifestyle; atopic dermatitis; human milk; food allergy; microbiome
• ISSN: 2296-2360; 2296-2360
• DOI: 10.3389/fped.2022.916184

Traditional farming lifestyle has been shown to be protective against asthma and allergic diseases. The individual factors that appear to be associated with this "farm-life effect" include consumption of unpasteurized farm milk and exposure to farm animals and stables. However, the biomarkers of the protective immunity and those associated with early development of allergic diseases in infancy remain unclear. The "Zooming in to Old Order Mennonites (ZOOM)" study was designed to assess the differences in the lifestyle and the development of the microbiome, systemic and mucosal immunity between infants born to traditional farming lifestyle at low risk for allergic diseases and those born to urban/suburban atopic families with a high risk for allergic diseases in order to identify biomarkers of development of allergic diseases in infancy. 190 mothers and their infants born to Old Order Mennonite population protected from or in Rochester families at high risk for allergic diseases were recruited before birth from the Finger Lakes Region of New York State. Questionnaires and samples are collected from mothers during pregnancy and after delivery and from infants at birth and at 1-2 weeks, 6 weeks, 6, 12, 18, and 24 months, with 3-, 4-, and 5-year follow-up ongoing. Samples collected include maternal blood, stool, saliva, nasal and skin swabs and urine during pregnancy; breast milk postnatally; infant blood, stool, saliva, nasal and skin swabs. Signs and symptoms of allergic diseases are assessed at every visit and serum specific IgE is measured at 1 and 2 years of age. Allergic diseases are diagnosed by clinical history, exam, and sensitization by skin prick test and/or serum specific IgE. By the end of the first year of life, the prevalence of food allergy and atopic dermatitis were higher in ROC infants compared to the rates observed in OOM infants as was the number of infants sensitized to foods. These studies of immune system development in a population protected from and in those at risk for allergic diseases will provide critical new knowledge about the development of the mucosal and systemic immunity and lay the groundwork for future studies of prevention of allergic diseases.